(Hypertension. 1995;25:431-436.)
© 1995 American Heart Association, Inc.
Articles |
Regulation of Neuronal Nitric Oxide Synthase in Rat Adrenal Medulla
From The First Department of Internal Medicine (N.I., M.K.) and Institute for Molecular Neurobiology (K.H., I.T.), Shiga University of Medical Sciences, Ohtsu, Shiga, and the Department of Neurobiology, Kyoto Pharmaceutical University (Y.K.), Yamashina, Kyoto, Japan.
Abstract Neuronal nitric oxide synthase (nNOS) has been suggested to be involved in cardiovascular homeostasis. We studied the regulation of nNOS expression, determining nNOS mRNA expression levels in various tissues in spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY). We also investigated the effects of antihypertensive treatment with the angiotensin II antagonist hydralazine or reserpine on nNOS mRNA expression. The expression levels of nNOS mRNA and nNOS protein were determined by Northern and Western blot analysis, respectively. NADPH-diaphorase histochemistry was used to identify cells in the adrenal medulla that expressed nNOS. No significant differences in expression levels in SHR and WKY were observed in the cerebellum and brain stem. nNOS mRNA expression levels in the decapsular portion of the adrenal gland were developmentally modulated and in a 24-week-old WKY were 2.5 times higher than in an age-matched SHR. This reduced expression of nNOS mRNA in the decapsular portion of the adrenal gland of SHR seemed to be a result of hypertension in the SHR, because administration of either an angiotensin II antagonist (TCV-116) or hydralazine upregulated nNOS mRNA expression in both SHR and WKY. Marked augmentation of nNOS mRNA expression in the decapsular portion of the adrenal gland by reserpine treatment suggested an intimate relation between nNOS in the decapsular portion of the adrenal gland and the sympathoadrenal system. Reserpine treatment also increased the expression of nNOS protein; however, reserpine treatment did not affect the distribution pattern of nNOS-positive cells (NADPH-diaphorase–positive cells) in the adrenal medulla. The present results suggest that nNOS gene expression in the decapsular portion of the adrenal gland is not constitutive and that an intimate relation may exist between nNOS in the decapsular portion of the adrenal gland and the sympathoadrenal system.
Key Words: nitric oxide • rats, inbred SHR • adrenal medulla • reserpine • angiotensin II • hydralazine
This article has been cited by other articles:
 |
|
 |
|
  F.-J. Lai, S.-S. Huang, M.-C. Hsieh, S.-C. Hsin, C.-H. Wu, Y.-C. Hsin, and S.-J. Shin Upregulation of Neuronal Nitric Oxide Synthase mRNA and Protein in Adrenal Medulla of Water-deprived Rats J. Histochem. Cytochem., January 1, 2005; 53(1): 45 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Tambascia, P. M. Fonseca, P. D. C. Corat, H. Moreno Jr, M. J. A. Saad, and K. G. Franchini Expression and Distribution of NOS1 and NOS3 in the Myocardium of Angiotensin II-Infused Rats Hypertension, June 1, 2001; 37(6): 1423 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Liu and I. H. Zucker Regulation of Sympathetic Nerve Activity in Heart Failure : A Role for Nitric Oxide and Angiotensin II Circ. Res., March 5, 1999; 84(4): 417 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Förstermann, J.-p. Boissel, and H. Kleinert Expressional control of the `constitutive' isoforms of nitric oxide synthase (NOS I and NOS III) FASEB J, July 1, 1998; 12(10): 773 - 790. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Takeda, I. Miyamori, T. Yoneda, K. Furukawa, S. Inaba, R. Takeda, and H. Mabuchi Brain Nitric Oxide Synthase Messenger RNA in Central Mineralocorticoid Hypertension Hypertension, October 1, 1997; 30(4): 953 - 956. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. F. Penson, C. Ng, J. Rajfer, and N. F. Gonzalez-Cadavid Adrenal Control of Erectile Function and Nitric Oxide Synthase in the Rat Penis Endocrinology, September 1, 1997; 138(9): 3925 - 3932. [Abstract] [Full Text] [PDF]
|
|